Compare MIRM & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIRM | CNOBP |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | N/A |
| IPO Year | 2019 | 1995 |
| Metric | MIRM | CNOBP |
|---|---|---|
| Price | $89.74 | $25.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $119.85 | N/A |
| AVG Volume (30 Days) | ★ 504.0K | 2.9K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | ★ N/A | $16.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.23 | $23.81 |
| 52 Week High | $130.00 | $25.51 |
| Indicator | MIRM | CNOBP |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 50.93 |
| Support Level | $88.08 | $25.15 |
| Resistance Level | $98.03 | $25.48 |
| Average True Range (ATR) | 3.98 | 0.07 |
| MACD | -0.60 | -0.01 |
| Stochastic Oscillator | 14.55 | 40.10 |
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.